文献速递慢性肾脏病

可溶性Klotho与肾功能变化之间的关联:健康、老龄与身体成分研究

Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study.
PubMed 文献 · J Am Soc Nephrol · 2017-01-19

在健康、老龄与身体成分研究的2496名老年人中,血清可溶性α-Klotho每升高两倍,估算肾小球滤过率下降30%的比值比为0.78,估算肾小球滤过率每年下降超过3 ml/min的比值比为0.85,但与新发慢性肾脏病的关联无统计学显著性。总体而言,较高的可溶性Klotho水平独立关联于较低的肾功能下降风险。

要点

  • 可溶性α-Klotho每升高两倍,估算肾小球滤过率下降30%的比值比为0.78。
  • 可溶性α-Klotho每升高两倍,估算肾小球滤过率每年下降超过3 ml/min的比值比为0.85。
  • 可溶性α-Klotho与新发慢性肾脏病的关联无统计学显著性,发生率比为0.90。

核心结论

  • 较高的可溶性Klotho水平独立关联于较低的肾功能下降风险。
  • 未来研究应在其他队列中重复这些结果并评估其潜在机制。

研究设计与样本

  • 健康、老龄与身体成分研究是一项老年人队列研究。
  • 共检测2496名参与者的血清可溶性α-Klotho。
  • 评估可溶性Klotho水平与肾功能下降(相对下降:估算肾小球滤过率下降≥30%;绝对下降:估算肾小球滤过率每年下降>3 ml/min)及新发慢性肾脏病(新发估算肾小球滤过率<60 ml/min/1.73 m²且每年下降>1 ml/min)的关联。
  • 模型校正了人口学特征、基线估算肾小球滤过率、尿白蛋白与肌酐比值、合并症及矿物质代谢指标。

主要发现

  • 参与者平均(标准差)年龄为75(3)岁,52%为女性,38%为黑人。
  • Klotho水平中位数(第25、75百分位数)为630(477,817)pg/ml。
  • 在完全校正模型中,Klotho每升高两倍,估算肾小球滤过率下降30%的比值比为0.78(95%置信区间0.66至0.93)。
  • 在完全校正模型中,Klotho每升高两倍,估算肾小球滤过率每年下降>3 ml/min的比值比为0.85(95%置信区间0.73至0.98)。
  • 在完全校正模型中,Klotho每升高两倍与新发慢性肾脏病的发生率比为0.90(95%置信区间0.78至1.04),关联无统计学显著性。

关键数值与推荐

  • 肾功能相对下降定义为估算肾小球滤过率下降≥30%。
  • 肾功能绝对下降定义为估算肾小球滤过率每年下降>3 ml/min。
  • 新发慢性肾脏病定义为新发估算肾小球滤过率<60 ml/min/1.73 m²且每年下降>1 ml/min。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来研究应在其他队列中重复这些结果并评估其潜在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CKD appears to be a condition of soluble klotho deficiency. Despite known associations between low soluble klotho levels and conditions that promote kidney damage, such as oxidative stress and fibrosis, little information exists regarding the longitudinal association between soluble klotho levels and change in kidney function. We assayed serum soluble α-klotho in 2496 participants within the Health Aging and Body Composition study, a cohort of older adults. The associations between soluble klotho levels and decline in kidney function (relative decline: eGFR decline ≥30%; absolute decline: eGFR decline >3 ml/min per year) and incident CKD (incident eGFR <60 ml/min per 1.73 m2 and >1 ml/min per year decline) were evaluated. We adjusted models for demographics, baseline eGFR, urine albumin-to-creatinine ratio, comorbidity, and measures of mineral metabolism. Among participants, the mean (SD) age was 75 (3) years, 52% were women, and 38% were black. Median (25th, 75th percentiles) klotho level was 630 (477, 817) pg/ml. In fully adjusted models, each two-fold higher level of klotho associated with lower odds of decline in kidney function (odds ratio, 0.78 [95% confidence interval, 0.66 to 0.93] for 30% decline in eGFR, and 0.85 [95% confidence interval, 0.73 to 0.98] for >3 ml/min per year decline in eGFR), but not of incident CKD (incident rate ratio, 0.90 [95% confidence interval, 0.78 to 1.04]). Overall, a higher soluble klotho level independently associated with a lower risk of decline in kidney function. Future studies should attempt to replicate these results in other cohorts and evaluate the underlying mechanism.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Drew DA, Katz R, Kritchevsky S, et al. Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study. J Am Soc Nephrol. 2017. PMID: 28104822. doi:10.1681/ASN.2016080828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。